Guest Post: Aloha Medicinals

August 8, 2017

Introduction to Medicinal Mushrooms

Practitioners of both Traditional Chinese Medicine (TCM) and Japanese Kampo medicine have administered medicinal mushrooms for many centuries for a wide variety of health conditions.
Medicinal mushrooms have a rich history of use and an important place in historical Materia Medica and modern science is now validating many of these traditional uses.
There are seven well known medicinal mushroom species approved for medicinal use by the Australian Therapeutic Goods Administration (TGA). A brief overview of each of these follows:

  • Cordyceps (Cordyceps sinensis) is unique among medicinal mushrooms in that it traditionally grows on an insect host. Cordyceps harvested in this way is still available, however there are now vegan friendly options that are cultivated without the need for an insect host. Traditionally used to tonify the lungs and improve energy and vitality.
  • Reishi (Ganoderma lucidum) is known as Ling Zhi (spirit mushroom or mushroom of spiritual potency) in Traditional Chinese Medicine (TCM). In Japanese Kampo medicine it is known as Mannetake (10,000 year mushroom or mushroom of immortality). Traditionally used to replenish qi and ease the mind.
  • Maitake (Grifola frondosa) is an edible mushroom with medicinal benefits. Typically used as an adaptogen and to support immune health through its immunomodulatory effects.
  • Shiitake (Lentinula edodes) is one of the most widely cultivated mushrooms and features prominently in Asian cuisine. It is used in some of the most popular medicinal mushroom products in the world due to its immune health benefits.
  • Lumpy Bracket (Polyporus umbellatus) is known as Zhu Ling in Traditional Chinese Medicine (TCM). Traditionally used as a diuretic and to remove damp, with modern use primarily for immune health.
  • Fu Ling (Poria cocos) is traditionally used as a diuretic. It is an important component in many Traditional Chinese Medicine (TCM) formulations due to its ability to reinforce and balance the effects of other herbal ingredients.
  • Turkey Tail (Trametes versicolor) is one of the most extensively researched medicinal mushrooms. Traditionally used to regulate immune function, a use that has been validated by modern research.

About Aloha Medicinals

Aloha Medicinals is one of the world’s leading producers of organically certified medicinal mushrooms, with a state of the art biotechnology facility. Located in the United States it is certified by the U.S. Food and Drug Administration and is compliant with FDA Good Manufacturing Practice (cGMP) regulations.

Aloha Medicinals’ patented Full Spectrum MycoProducts™ are grown via a proprietary solid substrate fermentation process utilising only certified organic raw materials. The proprietary cultivation process, combined with careful strain selection, guarantees a consistent and reproducible product. In fact, each product in the Full Spectrum Mycoproduct™ range is guaranteed to contain minimum of 50% total polysaccharides and 15% 1,3-1,6 beta glucan.
All mushroom strains are genetically verified through DNA sequencing, combined with traditional macroscopic and microscopic identification techniques, and every batch undergoes extensive third-party quality testing for heavy metals, pesticides, and other contaminants. The full range of medicinal mushroom products not only meet, but exceed the strict quality requirements of Australia’s highly regulated complementary medicines market.
Aloha Medicinals’ Full Spectrum Mycoproducts™ are gluten free, vegan friendly, excipient, solvent and pesticide free, organically certified and DNA verified.

The product range consists of the following seven well known medicinal mushroom species:

  • Cordyceps (Cordyceps sinensis)
  • Reishi (Ganoderma lucidum)
  • Maitake (Grifola frondosa)
  • Shiitake (Lentinula edodes)
  • Lumpy Bracket (Polyporus umbellatus)
  • Fu Ling (Poria cocos)
  • Turkey Tail (Trametes versicolor)

Author: Aloha Medicinals
Website: www.alohamedicinals.com

Pathway International is the exclusive distributor for Aloha Medicinals in Australia and New Zealand.
For more information please contact us on
Phone: 02 9984 2700
E-mail: sales@pathway.net.au
Website: www.pathway.net.au

Read More

Vitex to Expand Into the Aerotropolis
Read More >
Vitex CEO Dr Aniss Chami Appointed Board Director of CHP Australia
Read More >
Vitex Pharmaceuticals’ Chief Executive Officer, Dr Aniss Chami, a panel discussion with Blacktown City Council.
Vitex CEO Dr Aniss Chami Joins A Panel Discussion with Blacktown City Council
Read More >
Vitex Pharmaceuticals’ Chief Procurement Officer, Lucie Chami, discusses the impact of Coronavirus on procurement via Podcast on Chartered Institute of Procurement and Supply
Vitex CPO Lucie Chami Discusses the Impact of Coronavirus
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami shared the Vitex journey at the Advanced Manufacturing Symposium hosted by Blacktown City Council, on Thursday 24 October 2019 at Sydney Motorsport Park, Eastern Creek.
Vitex CEO Dr Aniss Chami Shares the Vitex Journey at the Advanced Manufacturing Symposium
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami delivered the keynote speech at the 16th edition of the World Forum for Foreign Direct Investment (FDI) 2019 held on Wednesday 19 June 2019 in Sydney, Australia.
Vitex CEO Dr Aniss Chami Delivers Keynote Speech at the 2019 World Forum for Foreign Direct Investment
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami joined the Western City & Aerotropolis Authority Industry Symposium that took place on Monday 16 December 2019 at Warwick Farm.
Vitex CEO Dr Aniss Chami Participates at the Western City & Aerotropolis Authority Industry Symposium
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami had the pleasure of hosting over forty foreign diplomats based in NSW. The Western Sydney Investment Attraction Office, on behalf of the Department of Foreign Affairs and Trade, organised a visit to Western Sydney to showcase investment and trade opportunities in this rapidly expanding region.
Vitex CEO Dr Aniss Chami Welcomes NSW Diplomats at Vitex Pharmaceuticals
Read More >
Vitex Pharmaceuticals’ CEO, Dr Aniss Chami delivered the keynote speech at the Inaugural International Foreign Direct Investment (FDI) Summit held on Tuesday 29 October 2019 in Huzhou, China.
Vitex CEO Dr Aniss Chami Delivers Keynote Speech at the International FDI Summit in Huzhou, China
Read More >